InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (21 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Farrell Peter C, Director. Insider active across 3 companies, notably RESMED INC. Aggregated, 40 reports have been published. Breakdown: 1 buy · 21 sells. Total volume traded: €13.1m. History available since 13 August 2021. The latest transaction was filed on 5 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Farrell Peter C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
8,000 shares@ US$225.000.0074% mcap10.9% of flowResMed Common StockSEC:0000943819-26-000040:0
2,000 shares@ US$225.004.1% of flowResMed Common StockSEC:0000943819-26-000019:0
2,000 shares@ US$260.223.5% of flowResMed Common StockSEC:0000943819-26-000014:0
2,000 shares@ US$251.313.3% of flowResMed Common StockSEC:0000943819-26-000010:0
2,000 shares@ US$248.833.3% of flowResMed Common StockSEC:0000943819-26-000004:0
2,000 shares@ US$251.473.8% of flowResMed Common StockSEC:0000943819-25-000186:0
536 shares0ResMed Common StockSEC:0000943819-25-000164:0
11,442 shares@ US$101.649.1% of flowResMed Common StockSEC:0000943819-25-000122:0
162.953 shares@ US$250.100.4% of flowResMed Common StockSEC:0000943819-25-000117:0
945 shares@ US$255.492.1% of flowResMed Common StockSEC:0000943819-25-000026:0
2,000 shares@ US$247.324.4% of flowResMed Common StockSEC:0000943819-25-000013:0
2,000 shares@ US$242.254.7% of flowResMed Common StockSEC:0001127602-25-013743:0
2,000 shares@ US$219.744.5% of flowResMed Common StockSEC:0001127602-25-011625:0
2,000 shares@ US$227.714.7% of flowResMed Common StockSEC:0001127602-25-008593:0
2,000 shares@ US$242.115.2% of flowResMed Common StockSEC:0001127602-25-003232:0
2,000 shares@ US$230.994.9% of flowResMed Common StockSEC:0001127602-25-000487:0
2,000 shares@ US$245.655.2% of flowResMed Common StockSEC:0001127602-24-028741:0
542 shares0ResMed Common StockSEC:0001127602-24-027893:0
527.905 shares@ US$252.381.4% of flowResMed Common StockSEC:0001127602-24-027102:0
2,000 shares@ US$248.745.0% of flowResMed Common StockSEC:0001127602-24-026799:0
2,000 shares@ US$237.204.8% of flowResMed Common StockSEC:0001127602-24-024898:0
2,000 shares@ US$239.904.8% of flowResMed Common StockSEC:0001127602-24-023609:0
3,131 shares0Common StockSEC:0001193805-24-000824:0
68,200 shares0ResMed Common StockSEC:0001127602-24-015779:0
12,600 shares@ US$237.172629.9% of flowResMed Common StockSEC:0001127602-24-006731:0
25 of 40 declarations
About Farrell Peter C
FARRELL PETER C is Administrateur and has filed 39 disclosures. In the recent filings available, they cover the period from 2016-01-06 to 2026-04-02, with EUR 91987 of purchases and EUR 11433333 of sales, and the most frequent transaction type is sale. They are linked to RESMED INC, Evolus, Inc. and Arcturus Therapeutics Holdings Inc., and the largest visible filings concern RESMED INC.
